ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

SPI Spire Healthcare Group Plc

248.00
2.50 (1.02%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Spire Healthcare Group Plc LSE:SPI London Ordinary Share GB00BNLPYF73 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  2.50 1.02% 248.00 247.50 248.00 248.00 247.00 247.00 225,483 16:29:33
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Health & Allied Services,nec 1.36B 27.3M 0.0676 36.69 1B

Spire Healthcare Group PLC Director/PDMR Shareholding (2648J)

28/03/2018 12:44pm

UK Regulatory


Spire Healthcare (LSE:SPI)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Spire Healthcare Charts.

TIDMSPI

RNS Number : 2648J

Spire Healthcare Group PLC

28 March 2018

28 March 2018

Spire Healthcare Group plc

Grant of 2018 Long Term Incentive Plan awards

Spire Healthcare Group plc (the "Company") announces that, on 28 March 2018, a performance share award (the "Award") was granted over the Company's ordinary shares in the form of nil cost options to the following Executive Director in the Company, under the rules of the Spire Healthcare Group plc Long Term Incentive Plan.

   Name                         Maximum number of shares under Award 
   Justin Ash                  576,058 

The number of shares set out above is the maximum number which may vest under the Award following the cessation of the performance period. The actual number of shares which vest will depend on the extent to which the following performance conditions have been satisfied.

The performance conditions applicable to the Award will be based as follows:

   --    35% on relative total shareholder return (TSR) performance; 
   --    35% on adjusted earnings per share (EPS) performance; and 
   --    30% on two Operational Excellence measures. 

Furher details of these performance conditions will be disclosed in the 2017 Directors' Remuneration Report which will be published in April.

The share price used to determine the number of shares under the Award was GBP2.1352 being the average of the middle market quotation over the last five dealing days ending on 27 March 2018.

The transaction place is London.

Name of contact and telephone number for queries:

   Philip Davies                                                 020 7427 9092 

Deputy Company Secretary

The following disclosure is made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014.

 
 
 a)    Name                                   Justin Ash 
----  -------------------------------------  ------------------------------------------- 
 2     Reason for the notification 
----  ---------------------------------------------------------------------------------- 
 a)    Position/status                        Chief Executive Officer 
----  -------------------------------------  ------------------------------------------- 
 b)    Initial notification                   Initial notification 
        /Amendment 
----  -------------------------------------  ------------------------------------------- 
 3     Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
----  ---------------------------------------------------------------------------------- 
 a)    Name                                   Spire Healthcare Group plc 
----  -------------------------------------  ------------------------------------------- 
 b)    LEI                                    213800IBJPW3SE2RA350 
----  -------------------------------------  ------------------------------------------- 
 4     Details of the transaction(s): section to be repeated for 
        (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transactions 
        have been conducted 
----  ---------------------------------------------------------------------------------- 
 a)    Description of                         Ordinary shares of 1 pence each 
        the financial 
        instrument, type                       GB00BNLPYF73 
        of instrument 
        Identification 
        code 
----  -------------------------------------  ------------------------------------------- 
 b)    Nature of the                          Grant of performance share awards under 
        transaction                            the Company's Long Term Incentive Plan 
----  -------------------------------------  ------------------------------------------- 
 c)    Price(s) and volume(s)                      Price(s)              Volume(s) 
----  -------------------------------------  --------------------  --------------------- 
                                Nil                                       576,058 
  ---------------------------------------------------------------  --------------------- 
 
 d)    Aggregated information                 As above 
        - Aggregated volume 
        - Price 
----  -------------------------------------  ------------------------------------------- 
 e)    Date of the transaction                2018-03-28 
----  -------------------------------------  ------------------------------------------- 
 f)    Place of the transaction               XLON 
----  -------------------------------------  ------------------------------------------- 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHBBGDXDSDBGII

(END) Dow Jones Newswires

March 28, 2018 07:44 ET (11:44 GMT)

1 Year Spire Healthcare Chart

1 Year Spire Healthcare Chart

1 Month Spire Healthcare Chart

1 Month Spire Healthcare Chart

Your Recent History

Delayed Upgrade Clock